IONS
#948
Ionis Pharmaceuticals, Inc. - Common Stock
56.7 5 USD
-0.03%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-2.58%
Changement Mensuel
-22.78%
Evolution sur 6 mois
-28.58%
Changement Annuel
-21.32%
Clôture Précédente
58.2 5
Open
56.7 5
Low
56.7 5
High
56.7 5
Volume
187
Financials
- Market Capitalization 9.38 B
- Employee 1 402
- Founded 1989
- CEO Brett P. Monia Ph.D.
- Website www.ionis.com
- Headquarter California, United States
- FIGI BBG000JH6683
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-33.24
ratio cours/chiffre d'affaires
13.41
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 906 |  CYTK Cytokinetics, Incorporated - Common Stock | 82.24 USD | -3.10% | -4.47% | +17.23% | +41.55% | 10.23 B USD | ||
| 924 |  NUVL Nuvalent, Inc. - Class A Common Stock | 123.94 USD | +0.03% | +0.19% | +0.52% | +30.53% | 9.79 B USD | ||
| 959 |  CORT Corcept Therapeutics Incorporated - Common Stock | 85.90 USD | -6.51% | -6.98% | +3.61% | +17.08% | 9.22 B USD | ||
| 967 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 110.40 USD | -7.50% | -4.18% | +27.97% | +86.80% | 9.08 B USD |